Hubei Bio-pharmaceutical Industrial Technological Institute Inc.

This is an early-stage study to check the safety and how the body processes a new ointment called HW211026. It will involve about 40 adults with actinic keratosis, a common pre-cancerous skin condition caused by sun damage. Researchers will apply the ointment to a small area of s…

This is the first study in humans to test the safety and how the body processes a new tablet called HW241045. The trial involves 56 healthy volunteers who will receive either the tablet or a placebo. Researchers will monitor for side effects and measure how the drug moves through…